BY Health & Biotech | Nadine McGrath • EZZ is reducing its reliance on Chinese e-commerce as it expands pharmacy distribution• Bubs is building the US while keeping China central to its growth plans• Vita Life is refining its China strategy as other Asian markets grow Cracking the Chinese market has long been the growth … Continue reading ASX health and wellness brands look beyond China for diversified growth